Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Scalable production of human cortical organoids using a biocompatible polymer

ABSTRACT: Scalable production of human cortical organoids using a biocompatible polymer

PROVIDER: PRJNA972757 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Scalable production of human cortical organoids using a biocompatible polymer

Project description:Single cell RNA-seq characterization of human induced pluripotent stem cells-derived human cortical organoids (hCO) cultured in control and XG-supplemented conditions Reference: Narazaki, Genta; Miura, Yuki; Pavlov, Sergey D.; Thete, Mayuri Vijay; Roth, Julien G.; Avar, Merve; Kim, Ji-il; Hudacova, Zuzana; Heilshorn, Sarah C.; Pașca, Sergiu P. Scalable production of human cortical organoids using a biocompatible polymer. GSE232581. DOI: (2025).

2025-03-18 | GSE232581 | GEO

Scalable production oftissue-like vascularised liver organoids from human PSCs.

Project description:Scalable production oftissue-like vascularised liver organoids from human PSCs.

| PRJNA1027911 | ENA

RNA-seq of Human Cortical Organoids Treated with Ciprofloxacin versus Untreated Controls

Project description:Human cortical organoids (hCOs) were employed to examine the developmental neurotoxic effects of ciprofloxacin (CPFX). Organoids were subjected to chronic exposure to low doses of CPFX for two weeks, while untreated organoids served as controls. Assessments included mitochondrial function, reactive oxygen species (ROS) production, and the expression of key neurodevelopmental regulators, including FOXG1, as well as genes associated with excitatory and inhibitory neuronal network formation. This study establishes a human-relevant model to investigate the molecular and functional consequences of CPFX exposure on cortical development.

2026-03-31 | E-MTAB-16792 | biostudies-arrayexpress

EVOLUTION OF THE LIPIDOME UNCOVERS EARLY CHANGES IN ADRENOLEUKODYSTROPHY HUMAN CORTICAL AND SPINAL ORGANOIDS

Project description:<p>Lipids are critical for the structure, signaling, and metabolism of the central nervous system (CNS), yet their roles during human brain development remain underexplored due to limited tissue availability. X-linked adrenoleukodystrophy (ALD), a peroxisomal disorder caused by ABCD1 mutations, disrupts very long-chain fatty acid (VLCFA) degradation, leading to axonal degeneration and demyelination. To investigate lipid dynamics in CNS development and ALD pathogenesis, we generated human induced pluripotent stem cell (hiPSC)-derived cortical and spinal cord organoids and performed lipidomics over 200 days. Lipidomic analysis revealed a dynamic lipidome, with changes in lipid abundance, saturation, and chain length reflecting neurodevelopment. ALD hiPSC-derived organoids exhibited significant lipid alterations over time, including elevated VLCFA levels and reductions in brain-relevant lipids, such as sulfatides and gangliosides, in cortical organoids. These findings provide a foundational resource for studying lipid dynamics in CNS development and emphasize the value of organoids for understanding ALD and other CNS diseases.</p>

2025-11-17 | MTBLS12973 | MetaboLights

Lis1 in human cortical organoids

Project description:Lysate analysis of WT or Lis1-mutant human cortical organoids

2025-03-11 | PXD040813 | Pride

Scalable production of uniform and mature organoids in a 3D geometrically-engineered permeable membrane

Project description:Scalable production of uniform and mature organoids in a 3D geometrically-engineered permeable membrane

| PRJNA1057805 | ENA

Modeling Focal Cortical Dysplasia (FCD) using cortical organoids

Project description:We generated cortical organoids from four FCD patients. To generate cortical organoids, we used induced pluriplotent stem cells (iPSCs) obtained from skin biopsy from these FCD selected patients and healthy controls. We extrated RNA samples from the cortical organoids to do customized panel of gene expression. Gene expression using NanoString Human Neuropathology Panel from four FCD patients and four controls

2022-01-01 | GSE174605 | GEO

Modeling Focal Cortical Dysplasia (FCD) using cortical organoids

Project description:Modeling Focal Cortical Dysplasia (FCD) using cortical organoids

| PRJNA730718 | ENA

Human cortical organoids. Chronic treatment with GSK3 inhibitor CHIR99021. Bulk RNAseq.

Project description:Here we used human cortical brain organoids to probe the longitudinal impact of GSK3 inhibition through multiple developmental stages. Chronic GSK3 inhibition increased the proliferation of neural progenitors and caused massive derangement of cortical tissue architecture. Cortical organoids were differentiated as previously described (Paşca et al., 2015, doi: 10.1038/nmeth.3415.).Chronic GSK3 inhibition was performed by adding CHIR99021 (Merck SML1046) to the medium at day 0 (1 microM) and kept throughout the differentiation process until reaching the respective collection timepoints (day 18, day 50, day 100).

2020-06-04 | E-MTAB-8325 | biostudies-arrayexpress

Scalable production of uniform and mature organoids in a 3D geometrically-engineered permeable membrane

Project description:The application of organoids has been limited by the lack of methods for producing uniformly mature organoids at scale. This study introduces an organoid culture platform, called UniMat, which addresses the challenges of uniformity and maturity simultaneously. UniMat is designed to not only ensure consistent organoid growth but also facilitate an unrestricted supply of soluble factors by a 3D geometrically-engineered, permeable membrane-based platform. Using UniMat, we demonstrate the scalable generation of kidney organoids with enhanced uniformity in both structure and function compared to conventional methods. Notably, kidney organoids within UniMat matured significantly better, showing increased expression of nephron transcripts, more in vivo-like cell-type balance, and better vascularization. Moreover, UniMat's design offers a more standardized organoid model for drug testing, as demonstrated by its consistent response to a polycystic-kidney-disease drug. In essence, UniMat presents a transformative platform for organoid technology, promising applications in organ development, disease modeling, and drug screening.

2024-09-07 | GSE252104 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data